analyzer (Sequenom, Inc.) via sequencing. These eight SNPs were selected from the dbSNP database (www.ncbi.nlm.nih.gov/SNP), in which rs766736182 and rs762037062 are missense SNPs, rs1545228 and rs2583759 locate at 3'UTR, rs1441850, rs1119642, and rs11777564
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locate at intron region, and rs145230246 locates at 5'UTR.
| PCRsystem
The 50 μL PCR reaction system is as follows: 2 μL DNA, 2 μL of primers, 0.25 μL Taq enzyme, 4 μL dNTP, 5 μL PCR buffer, and add water to a final volume of 50 μL to build the reaction mixture. Thereafter, initial denaturation for 5 minutes at 94°C. Thirty-nine amplification cycles were performed using the following conditions: 94°C for 30 s, 52.7°C
for 50 s, 72°C for 45 s. Finally, it is the 5 minutes extension at 72°C.
| Statisticalanalysis
The chi-squared test was performed to decide genotype frequencies and allele differences between asthma patients and healthy controls, and the odds ratio (OR) with a 95% confidence interval (CI) was used to decide relative risk. Hardy-Weinberg equilibrium (HWE) tests were for data quality control using R. linkage disequilibrium (LD) was measured by R 2 . All P-values are two-tailed value and are statistical significant when <0.05.
| RE SULTS

| rs766736182associateswiththeriskofasthma
The case-control study involved 437 asthma patients (216 boys and 221 girls with a mean age ± SD of 4.1 ± 3.16 years) and 489 age-matched healthy controls (227 boys and 224 girls with a mean age ± SD of 4.62 ± 3.69 years ( Table 1) . Distributions of the genotypes of the eight SNPs in all age-matched healthy controls and in most of the patients were in Hardy-Weinberg equilibrium (HWE), except for rs766736182 in asthma patients ( Table 2 ). The rs766736182 showed significant differences between asthma patients and healthy controls in both allele frequencies and genotype frequencies (P-value < 0.05). The other seven of tested SNPs showed no significant differences in either allele frequencies or genotype frequencies between asthma patients (n = 437) and controls (n = 489) for seven of tested SNPs ( Table 2 ). The G allele frequency of rs766736182 was higher in asthma patients than that in controls (P-value = 8.69468E-19, OR = 2.185, 95%
confidence interval CI = 1.561-2.252). The genotype frequencies of rs766736182 (P-value = 8.69468E-19) was significantly different between asthma patients and controls, respectively. The other seven of the tested SNPs showed no significant differences in allele frequencies or genotype frequencies between asthma patients (n = 437) and controls (n = 489) for seven of the tested SNPs (Table 2) . Moreover, no significant differences in allele frequencies or genotype frequencies of rs766736182 were observed between asthma patients in different stages (Table 3) .
| Linkagedisequilibriumanalysis
The linkage disequilibrium (LD) analysis revealed that only rs1441850 and rs1545228 showed strong LD with each other (R 2 > 0.8) (Table 4 ). Other SNP pairs only showed modest or weak LD, as evidenced by low R 2 value, especially for SNP pairs involving rs145230246, rs766736182, and rs762037062 (Table 4) . It suggests that most of analyzed SNPs perform their function independently in the studied population, which make building haplotypes unnecessary in this study.
| D ISCUSS I ON
Asthma is a long-term respiratory disease characterized by variable and recurring symptoms, reversible airflow obstruction, and bronchospasm, and begins in childhood.
